You Usually Do Not Need To Be RhoC Hooked To Get Stung

Матеріал з HistoryPedia
Версія від 04:53, 26 квітня 2017, створена Bumper0hook (обговореннявнесок) (Створена сторінка: A review of the literature of Rosai-Dorfman disease involving the breast is also presented. ""Abstract:? Some patients with small (��1.0?cm) node-negative (...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

A review of the literature of Rosai-Dorfman disease involving the breast is also presented. ""Abstract:? Some patients with small (��1.0?cm) node-negative (T1a,bN0) invasive breast cancer (IBC) who undergo only local therapy experience recurrences. There is limited information on prognostic factors in these patients. We sought to identify prognostic factors associated with disease-free survival (DFS) and overall survival (OS) in patients with T1a,bN0 IBC. Histologic sections from 273 T1a,bN0 IBC patients treated at M. D. Anderson Cancer Center (MDACC) between 1980 and 1999 were reviewed. Microscopic tumor size; multifocality; histologic type, grade of tumor; presence, type, grade of associated ductal carcinoma in situ (DCIS); presence of fibrocystic changes Selleck ZVADFMK (FCC) with/without atypia; and lymphovascular invasion were identified. The Kaplan�CMeier method was used to evaluate DFS and OS. Median patient age was 58?years, median follow-up period was 10.8?years, and median tumor size was 0.8?cm. Multifocal disease was identified in 26% of cases. At 10?years, the DFS and OS rates were 91% and 88%, respectively. Twenty-one percent of patients had extensive (>50%), and 30% had grade 3 DCIS. Nonproliferative FCC and proliferative FCC with/without atypia were present in 80%, 36%, and 38% of patients, respectively. In univariate analysis, RhoC age at diagnosis (p?Smad inhibitor between 1999 and 2007. We identified 130 patients who had a positive SLN but did not undergo completion ALND. We evaluated clinical data, adjuvant treatment patterns and intermediate locoregional and distant events. The median patient age was 50; 19% had N0(i+) disease, 53% had micrometastatic (N1mi) disease, and 28% had macrometastasis. Eighty-eight percent of patients underwent radiation therapy; 66 patients (51%) had documented nodal radiation (of these 50 were treated with three fields and 14 with high tangents.